Matarin Capital Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $2.02M | Sell |
|
|||||
|
2020
Q2 | $2.83M | Sell |
|
|||||
|
2020
Q1 | $4.06M | Sell |
|
|||||
|
2019
Q4 | $10.2M | Sell |
|
|||||
|
2019
Q3 | $13.8M | Buy |
|
|||||
|
2019
Q2 | $11.3M | Buy |
|
|||||
|
2019
Q1 | $6.51M | Sell |
|
|||||
|
2018
Q4 | $5.46M | Buy |
|
|||||
|
2018
Q3 | $8.14M | Buy |
|
|||||
|
2018
Q2 | $1.52M | Buy |
|
|||||
|
2018
Q1 | $208K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $8.16M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $286K | Buy |
|